Zentalis Pharmaceuticals Inc (ZNTL)
11.07
+0.08
(+0.77%)
USD |
NASDAQ |
Apr 26, 16:00
11.07
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Total Assets (Quarterly): 551.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 551.69M |
| September 30, 2023 | 585.72M |
| June 30, 2023 | 621.44M |
| March 31, 2023 | 489.34M |
| December 31, 2022 | 539.31M |
| September 30, 2022 | 529.19M |
| June 30, 2022 | 567.86M |
| March 31, 2022 | 405.68M |
| December 31, 2021 | 454.51M |
| Date | Value |
|---|---|
| September 30, 2021 | 435.08M |
| June 30, 2021 | 283.96M |
| March 31, 2021 | 328.35M |
| December 31, 2020 | 365.56M |
| September 30, 2020 | 393.23M |
| June 30, 2020 | 257.22M |
| March 31, 2020 | 87.63M |
| December 31, 2019 | 87.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
87.48M
Minimum
Dec 2019
621.44M
Maximum
Jun 2023
410.78M
Average
435.08M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Revolution Medicines Inc | 2.062B |
| Day One Biopharmaceuticals Inc | 376.05M |
| Perspective Therapeutics Inc | 97.89M |
| Electromed Inc | 46.96M |
| Xtant Medical Holdings Inc | 92.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.30M |
| Shareholders Equity (Quarterly) | 437.28M |